Sound waves and a drug team up to attack returning brain tumors

NCT ID NCT06039709

First seen Apr 30, 2026 · Last updated Apr 30, 2026

Summary

This pilot study is for people with recurrent glioblastoma, a serious brain cancer that has come back. It tests a new approach called sonodynamic therapy, which combines an investigational drug (5-ALA) with focused ultrasound waves guided by a brain-mapping system. The goal is to see if this treatment is safe and can damage cancer cells before the patient undergoes surgery to remove the tumor. Only 11 participants will be enrolled in this early-stage study.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECURRENT GLIOBLASTOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Virginia

    RECRUITING

    Charlottesville, Virginia, 22903, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.